OBJECTIVES: To describe neurodevelopmental outcomes in infants with single ventricle (SV) physiology and determine factors associated with worse outcomes. STUDY DESIGN:Neurodevelopmental outcomes for infants with SV enrolled in a multicenter drug trial were assessed at 14 months of age using the Bayley Scales of Infant Development-II. Multivariable regression analysis was used to identify factors associated with worse outcomes. RESULTS: Neurodevelopmental testing was performed at 14 ± 1 months in 170/185 subjects in the trial. Hypoplastic left heart syndrome was present in 59% and 75% had undergone the Norwood operation. Mean Psychomotor Developmental Index (PDI) and mental developmental index (MDI) were 80 ± 18 and 96 ± 14, respectively, (normal 100 ± 15, P < .001 for each). Group-based trajectory analysis provided a 2-group model ("high" and "low") for height z-score trajectory and brain type natriuretic peptide (BNP) trajectory. The predicted PDI scores were 15 points higher in the "high" height z-score trajectory compared with the "low" cluster (P < .001). A higher number of serious adverse events during the trial was associated with lower PDI scores (P = .02). The predicted MDI scores were 13-17 points lower in "low height trajectory-high BNP trajectory" group compared with the other 3 groups (P < .001). MDI scores were also lower in subjects who required extracorporeal membrane oxygenation during the neonatal hospitalization (P = .01) or supplemental oxygen at discharge (P = .01). CONCLUSIONS:Neurodevelopmental outcome at 14 months of age is impaired in infants with SV physiology. Low height trajectory and high BNP trajectory were associated with worse neurodevelopmental outcomes. Efforts to improve nutritional status alone may not improve neurodevelopmental outcomes.
RCT Entities:
OBJECTIVES: To describe neurodevelopmental outcomes in infants with single ventricle (SV) physiology and determine factors associated with worse outcomes. STUDY DESIGN: Neurodevelopmental outcomes for infants with SV enrolled in a multicenter drug trial were assessed at 14 months of age using the Bayley Scales of Infant Development-II. Multivariable regression analysis was used to identify factors associated with worse outcomes. RESULTS: Neurodevelopmental testing was performed at 14 ± 1 months in 170/185 subjects in the trial. Hypoplastic left heart syndrome was present in 59% and 75% had undergone the Norwood operation. Mean Psychomotor Developmental Index (PDI) and mental developmental index (MDI) were 80 ± 18 and 96 ± 14, respectively, (normal 100 ± 15, P < .001 for each). Group-based trajectory analysis provided a 2-group model ("high" and "low") for height z-score trajectory and brain type natriuretic peptide (BNP) trajectory. The predicted PDI scores were 15 points higher in the "high" height z-score trajectory compared with the "low" cluster (P < .001). A higher number of serious adverse events during the trial was associated with lower PDI scores (P = .02). The predicted MDI scores were 13-17 points lower in "low height trajectory-high BNP trajectory" group compared with the other 3 groups (P < .001). MDI scores were also lower in subjects who required extracorporeal membrane oxygenation during the neonatal hospitalization (P = .01) or supplemental oxygen at discharge (P = .01). CONCLUSIONS: Neurodevelopmental outcome at 14 months of age is impaired in infants with SV physiology. Low height trajectory and high BNP trajectory were associated with worse neurodevelopmental outcomes. Efforts to improve nutritional status alone may not improve neurodevelopmental outcomes.
Authors: George M Hoffman; Kathleen A Mussatto; Cheryl L Brosig; Nancy S Ghanayem; Ndidiamaka Musa; Raymond T Fedderly; Robert D B Jaquiss; James S Tweddell Journal: J Thorac Cardiovasc Surg Date: 2005-10 Impact factor: 5.209
Authors: Amanda J Shillingford; Richard F Ittenbach; Bradley S Marino; Jack Rychik; Robert R Clancy; Thomas L Spray; J William Gaynor; Gil Wernovsky Journal: Cardiol Young Date: 2007-03-05 Impact factor: 1.093
Authors: Karen J Visconti; David Rimmer; Kimberlee Gauvreau; Pedro del Nido; John E Mayer; Ikou Hagino; Frank A Pigula Journal: Ann Thorac Surg Date: 2006-12 Impact factor: 4.330
Authors: J William Gaynor; Marsha Gerdes; Elaine H Zackai; Judy Bernbaum; Gil Wernovsky; Robert R Clancy; Mark F Newman; Ann M Saunders; Patrick J Heagerty; Jo Ann D'Agostino; Donna McDonald-McGinn; Susan C Nicolson; Thomas L Spray; Gail P Jarvik Journal: J Thorac Cardiovasc Surg Date: 2003-12 Impact factor: 5.209
Authors: Daphne T Hsu; Seema Mital; Chitra Ravishankar; Renee Margossian; Jennifer S Li; Lynn A Sleeper; Richard V Williams; Jami C Levine; Brian W McCrindle; Andrew M Atz; Darlene Servedio; Lynn Mahony Journal: Am Heart J Date: 2009-01 Impact factor: 4.749
Authors: Sally Grantham-McGregor; Yin Bun Cheung; Santiago Cueto; Paul Glewwe; Linda Richter; Barbara Strupp Journal: Lancet Date: 2007-01-06 Impact factor: 79.321
Authors: Daniel J Raiten; Alison L Steiber; Susan E Carlson; Ian Griffin; Diane Anderson; William W Hay; Sandra Robins; Josef Neu; Michael K Georgieff; Sharon Groh-Wargo; Tanis R Fenton Journal: Am J Clin Nutr Date: 2016-01-20 Impact factor: 7.045
Authors: Mark A Fogel; Christine Li; Felice Wilson; Tom Pawlowski; Susan C Nicolson; Lisa M Montenegro; Laura Diaz Berenstein; Thomas L Spray; J William Gaynor; Stephanie Fuller; Marc S Keller; Matthew A Harris; Kevin K Whitehead; Robert Clancy; Okan Elci; Jim Bethel; Arastoo Vossough; Daniel J Licht Journal: Heart Date: 2015-06-05 Impact factor: 5.994
Authors: Mark A Fogel; Tom Pawlowski; Peter J Schwab; Susan C Nicolson; Lisa M Montenegro; Laura Diaz Berenstein; Thomas L Spray; J William Gaynor; Stephanie Fuller; Marc S Keller; Matthew A Harris; Kevin K Whitehead; Arastoo Vossough; Daniel J Licht Journal: Ann Thorac Surg Date: 2014-08-19 Impact factor: 4.330
Authors: Sean J Cooney; Kristen Campbell; Kelly Wolfe; Michael V DiMaria; Christopher M Rausch Journal: Pediatr Cardiol Date: 2020-11-15 Impact factor: 1.655
Authors: J William Gaynor; Christian Stopp; David Wypij; Dean B Andropoulos; Joseph Atallah; Andrew M Atz; John Beca; Mary T Donofrio; Kim Duncan; Nancy S Ghanayem; Caren S Goldberg; Hedwig Hövels-Gürich; Fukiko Ichida; Jeffrey P Jacobs; Robert Justo; Beatrice Latal; Jennifer S Li; William T Mahle; Patrick S McQuillen; Shaji C Menon; Victoria L Pemberton; Nancy A Pike; Christian Pizarro; Lara S Shekerdemian; Anne Synnes; Ismee Williams; David C Bellinger; Jane W Newburger Journal: Pediatrics Date: 2015-05 Impact factor: 7.124
Authors: Matthew W Linakis; Joseph E Rower; Susan Sorenson; Christopher A Reilly; Linda M Lambert; Richard V Williams; Phillip T Burch Journal: J Pediatr Pharmacol Ther Date: 2020
Authors: Kristi L Fogg; Diane M DellaValle; Jason R Buckley; Eric M Graham; Sinai C Zyblewski Journal: Pediatr Cardiol Date: 2016-04-18 Impact factor: 1.655